Ipsen

Health Canada Greenlights Bylvay by Medison and Ipsen: A Breakthrough Treatment for ALGS
Health Canada has approved Bylvay (odevixibat), developed by Medison Pharma and Ipsen, to treat cholestatic pruritus in patients aged 12 ... Read more

Health Canada has approved Bylvay (odevixibat), developed by Medison Pharma and Ipsen, to treat cholestatic pruritus in patients aged 12 ... Read more